Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CARR, DEBORAH D | 1 | 81.7% | +2.8% |
| CLAYTOR, DEIRDRE RENEE | 1 | 42.8% | +26.9% |
| INAM, SAHAR | 1 | 100.0% | +0.0% |
| HAQ, SHAFIQUL | 1 | 64.9% | +55.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18772745 | SITE-SPECIFIC ISOTOPIC LABELING OF 1,4-DIENE SYSTEMS | CARR, DEBORAH D | — |
| 18275972 | Methods for Inhibiting the Progression of Neurodegenerative Diseases | INAM, SAHAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18291016 | Methods for Inhibiting the Progression of Oxidative Retinal Disease | CLAYTOR, DEIRDRE RENEE | 70d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18167781 | METHODS FOR MONITORING PATIENT RESPONSE TO TREATMENT OF RETINAL OXIDATIVE DISEASES | HAQ, SHAFIQUL | 46d |
| 18291016 | Methods for Inhibiting the Progression of Oxidative Retinal Disease | CLAYTOR, DEIRDRE RENEE | 70d |
| Art Unit | Apps |
|---|---|
| 1691 | 2 |
| 1622 | 1 |
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18772745 | SITE-SPECIFIC ISOTOPIC LABELING OF 1,4-DIENE SYSTEMS | CARR, DEBORAH D | 1691 | §112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18291016 | Methods for Inhibiting the Progression of Oxidative Retinal Disease | CLAYTOR, DEIRDRE RENEE | 1691 | §102§103§112 | Non-Final OA | 70d | Pending | Jan 22, 2024 |
| 18275972 | Methods for Inhibiting the Progression of Neurodegenerative Diseases | INAM, SAHAR | 1622 | §102§103§112DP | Non-Final OA | — | Pending | Aug 04, 2023 |
| 18167781 | METHODS FOR MONITORING PATIENT RESPONSE TO TREATMENT OF RETINAL OXIDATIVE DISEASES | HAQ, SHAFIQUL | 1678 | §103Other | Non-Final OA | 46d | Pending | Feb 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial